Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials
Lingdi Zhao, Wei Li, Huiying Zhang, Nan Hou, Lanwei Guo, Quanli Gao Department of Cancer Biotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, People’s Republic of ChinaPurpose: Data on the role of angiogenesis inhibitors (AIs) rechallenge in the tr...
Main Authors: | Zhao LD, Li W, Zhang HY, Hou N, Guo LW, Gao QL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/angiogenesis-inhibitors-rechallenge-in-patients-with-advanced-non-smal-peer-reviewed-article-OTT |
Similar Items
-
Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient
by: Briasoulis Evangelos, et al.
Published: (2010-07-01) -
Immunotherapy rechallenge in patients with non-small-cell lung cancer
by: S. España, et al.
Published: (2020-07-01) -
Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
by: Yuki Katayama, et al.
Published: (2019-12-01) -
Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy
by: Caitlyn N. Myrdal, et al.
Published: (2020-01-01) -
Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib
by: Riziero Esposito Abate, et al.
Published: (2019-09-01)